Albireo Pharma | Results Presentation Deck | 18 slides

Albireo Pharma · 2022-10
arc beats above · slides in the middle · loops below · scroll → 1 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

3
coverage by narrative range · generated from this deck JSON

Slide inventory

18
every slide · same image gating as the playbook
01
Slide 1
front_matter
02
front_matter
03
introduce_nominees
04
The slide uses a stylized logo for the ASSERT study.front_matter
05
The chart uses stacked bars to represent cumulative patient population growth associated with clinical trial programs (PEDFIC, ASSERT, BOLD).size_opportunity
06
Includes a photo of a child with medical equipment to humanize the disease impact.frame_problem
Open slide detailBeat · Problem
07
The slide outlines a standard randomized controlled trial (RCT) design for a pharmaceutical study.present_framework
Open slide detailBeat · Agitate
08
The slide includes a footer note regarding patient completion rates.analyze_data
Open slide detailBeat · Agitate
09
Clinical trial data showing efficacy of Odevixibat (Bylvay) vs Placebo.analyze_data
Open slide detailBeat · SolutionLoop · Before After
10
The chart displays LS Mean (95% CI) with p-value significance markers.analyze_data
Open slide detailBeat · SolutionLoop · Before After
11
The chart shows statistically significant improvements (p<=0.01) for the treatment group across all time points after baseline.analyze_data
Open slide detailBeat · SolutionLoop · Before After
12
The p-values indicate statistical significance for the listed improvements.summarize
Open slide detailBeat · SolutionLoop · Before After
13
The slide highlights safety data for Odevixibat (Bylvay) over 24 weeks.analyze_data
Open slide detailBeat · Solution
14
summarize
Open slide detailBeat · Solution
15
introduce_nominees
16
summarize
17
The slide uses three distinct cards to represent different strategic pillars (regulatory, clinical, commercial).plan_implementation
18
front_matter